Chemistry: molecular biology and microbiology – Treatment of micro-organisms or enzymes with electrical or... – Modification of viruses
Patent
1996-04-17
1998-01-27
Elliott, George G.
Chemistry: molecular biology and microbiology
Treatment of micro-organisms or enzymes with electrical or...
Modification of viruses
4352351, 4353201, 530350, C12N 1509, C12N 1586, C12N 701, C07K 14075
Patent
active
057121362
ABSTRACT:
A method of introducing an adenovirus into a cell that comprises a particular cell surface binding site, as well as a chimeric adenovirus penton base protein and recombinant adenoviral vector comprising the chimeric adenovirus penton base protein for use in the method, are provided.
REFERENCES:
patent: 4487829 (1984-12-01), Sharp et al.
patent: 4593002 (1986-06-01), Dulbecco
patent: 5223409 (1993-06-01), Ladner et al.
patent: 5332567 (1994-07-01), Goldenberg
patent: 5349053 (1994-09-01), Landolfi
patent: 5403484 (1995-04-01), Ladner et al.
patent: 5443953 (1995-08-01), Hansen et al.
patent: 5521291 (1996-05-01), Curiel et al.
patent: 5543328 (1996-08-01), McClelland et al.
patent: 5547932 (1996-08-01), Curiel et al.
patent: 5559099 (1996-09-01), Wickham et al.
patent: 5571698 (1996-11-01), Ladner et al.
Karyan et al., Virology, 202, 782-785 (1994).
Bai et al., J. Virol., 67, 5198-5205 (1993).
Batra et al., Gene Therapy, 1, 255-260 (1994).
Boursnell et al., Gene, 13, 311-317 (1981).
Chu et al., Gene Therapy, 1, 292-299 (1994).
Cotten et al., Proc. Natl. Acad. Sci., 87, 4033-4037 (1990).
Cotten et al., Proc. Natl. Acad. Sci., 89, 6094-6098 (1992).
Crystal, Science, 270, 404-410 (1995).
Curiel et al., Human Gene Therapy, 3, 147-154 (1992).
Curiel et al., Proc. Natl. Acad. Sci., 88, 8850-8854 (1991).
Dupuit et al., Human Gene Therapy, 6, 1185-1193 (1995).
Falgout et al., J. Virol., 62, 622-625 (1992).
Grubb et al., Nature, 371, 802-806 (1994).
Henry et al., J. Virol., 68 (8), 5239-5246 (1994).
Horvath et al., J. Virol., 62, 341-345 (1988).
Huang et al., J. Virol., 69, 2257-2263 (1995).
Kass-Eisler et al., Proc. Natl Acad. Sci., 90, 11498-11502 (1993).
Maraveyas et al., Acta Oncologica, 32, 741-746 (1993).
Mastrangeli et al., Ped. Pulm., Suppl. 12, 230, Ab. No. 180 (1995).
Mastrangeli et al., Human Gene Therapy, 7, 79-87 (1996).
Mathias et al., J. Virol., 68, 6811-6814 (1994).
Michael et al., The Journal of Biological Chemistry, 268, 6866-6869 (1993).
Michael et al., Gene Therapy, 2, 660-668 (1995).
Michael et al., "Addition of Short Peptide Ligand Sequences to the Adenovirus Fiber Protein," presented at Adenovirus Workshop: St. Andrews University, p. 52 (Jul. 13-15, 1995).
Miller et al., FASEB J., 9, 190-199 (1995).
Nemerow et al., In Biology of Vitronectins and their Receptors (Preissner et al., eds.), 177-184 (Elsevier Science Publishers, 1993).
Nemerow et al., Trends in Cell Biology, 4, 52-55 (1994).
Novelli et al., Virology, 185, 365-376 (1991).
Russell et al., Nucleic Acids Research, 21, 1081-1085 (1993).
Signas et al., J. Virol., 53, 672-678 (1985).
Silver et al., Virology, 165, 377-387 (1988).
Wagner et al., Proc. Natl. Acad. Sci., 89, 6099-6103 (1992).
Watkins et al., "Targeting Adenovirus-Mediated Gene Delivery with Recombinant Antibodies", presented at Keystone Symposium on Molecular and Cellular Biology, Abst. No. 336 (Taos: NM, Feb. 22-28, 1996).
Wickham et al., Cell, 73, 309-319 (1993).
Wickham et al., J. Cell. Biol., 127, 257-264 (1994).
Wickham et al., Gene Therapy, 2, 750-756 (1995).
Etienne-Julan et al., "The efficiency of cell targeting by recombinant retroviruses depends on the nature of the receptor and the composition of the artificial cell-virus linker", J. Gen. Virol. 73:3251-3255, 1992.
Orkin et al., "Report and recommendations of the panel to access the NIH investment in research on gene therapy", Dec. 1995.
Brough Douglas E.
Bruder Joseph T.
Kovesdi Imre
McVey Duncan L.
Roelvink Petrus W.
Elliott George G.
GenVec, Inc.
Schwartzman Robert
LandOfFree
Adenoviral-mediated cell targeting commanded by the adenovirus p does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Adenoviral-mediated cell targeting commanded by the adenovirus p, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Adenoviral-mediated cell targeting commanded by the adenovirus p will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-341118